April 18 (Reuters) - Bard1 Life Sciences Ltd BD1.AX :
* Says gives update on status of its lung cancer diagnostics program
* Says it had expected to announce results of its lung cancer by end of March 2017
* Bard1 Life Sciences says data is still undergoing analysis and determine performance of Bard1 test for early detection of lung cancer
* Bard1 life sciences says to report results of study after completion of analysis; process expected to take up to 8 weeks Source text for Eikon: Further company coverage: BD1.AX